TOP PHARM CO.,LIMITED
Place of Origin: | China |
Brand Name: | Top Pharm |
Certification: | IOS 901 |
Model Number: | 601-63-8 |
Minimum Order Quantity: | 10g |
---|---|
Price: | Negotiable |
Packaging Details: | As your requirments |
Delivery Time: | 3-6 working days |
Payment Terms: | T/T, Western Union, MoneyGram,bitcoin |
Supply Ability: | bulk stock |
Appearance: | White Or Oyster White To Pale Yellow Crystalline | Other Names: | Nandrolone Laurate |
---|---|---|---|
Purity: | 99% | Molecular Weight: | 428.65 |
Molecular Formula: | C28H44O3 | ||
High Light: | Nandrolone Decanoate,Anabolic Steroid Injectable Nandrolone Decanoate,CAS 360-70-3 Nandrolone Decanoate |
Nandrolone Decanoate
Chemical Name: 4-estren-17beta-ol-3-one decanoate
CAS NO.: 360-70-3
Molecular Formula: C28H44O3
Molecular weight: 428.65
Appearance: white or oyster white to pale yellow crystalline powder
Standard: USP28; BP2003
Introduction: The use of androgenic-anabolic steroids (AAS) among bodybuilders to increase muscle mass is widespread. Nandrolone decanoate (ND) is one of the most popular misused AAS, although the effects on body composition are equivocal. Therefore, the purpose of this study was to determine the effect of ND on body composition in male bodybuilders, with special reference to muscle mass alterations.
Methods: Using a randomized "double-blind" "placebo-controlled" design, 16 experienced male bodybuilders (age: 19-44 yr) either received ND (200 mg.wk(-1), intramuscularly) or placebo for 8 wk. Body composition was assessed using the four-component model, combining results from underwater weighing, dual-energy x-ray absorptiometry (DXA), and deuterium dilution. Total bone mineral content and density were measured using DXA. Water compartments (extracellular water [ECW] and intracellular water [ICW]) were determined using deuterium dilution and bromide dilution.
Results: ND administration resulted in significant increments of body mass (+2.2 kg), fat-free mass (FFM: +2.6 kg), and total body water (+1.4 kg). No significant changes in fat mass, percentage fat, ECW, ICW, ECW/ICW ratio, hydration of the FFM, and on bone mineral measurements were observed.
Conclusions: The results show that the administration of 200 mg.wk(-1) of ND (intramuscularly) for 8 wk significantly increased body mass and FFM, whereas fat mass, bone mineral content, bone mineral density, and the hydration of the FFM remained unaffected. These data indicate that the changes can be attributed to an increase of muscle mass.
Nandrolone Decanoate is used in the treatment of anemia resultant of renal insufficiency, as well as off-label for cachexia, osteoporosis, and wasting syndrome.
Nandrolone decanoate is a medication that is available only by prescription due to its high likelihood of being abused, as well as the severe side effects that may arise if it is improperly administered. Some indications for receiving intramuscular nandrolone decanoate injections include the following:
Aplastic anemia: Studies have shown that nandrolone decanoate injections may be of benefit in the management of patients with aplastic anemia, a condition that arises from the damage to the bone marrow cells within the body. The research done revealed a positive correlation between the long-term administration of the nandrolone decanoate injection and improvement in symptoms of aplastic anemia; in some subjects, the red blood cell levels returned to normal.
Hemodialysis: Patients on chronic hemodialysis as a result of end-stage renal disease are predisposed to developing anemia due to reduced production of erythropoietin; exogenous erythropoietin may be administered to these individuals to boost their production of red blood cells. Several studies have indicated that nandrolone decanoate injections enhance the sensitivity of erythroid precursor cells to erythropoietin; patients on hemodialysis who received a combination of exogenous erythropoietin and nandrolone injections as part of their treatment regimen showed a significant improvement in their hematocrit and hemoglobin values. Additionally, nandrolone injections increased the nutritional status and the lean body mass of patients on hemodialysis as they experienced marked improvements in serum albumin levels as well as other markers of nutritional status.
Osteoporosis: Nandrolone decanoate injections have been shown to help minimize and even reverse the loss of bone density that is associated with osteoporosis. It acts by inhibiting bone resorption resulting in a corresponding increase in bone formation. In addition, it causes an increase in the content of bone minerals at the proximal and distal radius, as well as at the lumbar spine. All these effects significantly reduce the incidence of fractures that are typically associated with osteoporosis.
Cachexia: Nandrolone decanoate injections may be helpful in the management of muscle wasting in individuals who have chronic diseases such as cancer and HIV, as well as burins and liver failure. Administration of nandrolone to these individuals may help them develop some muscle mass and, thereby, improve their physical appearance.
Store this medication at 68°F to 77°F (20°C to 25°C) and away from heat, moisture and light. Keep all medicine out of the reach of children. Throw away any unused medicine after the beyond use date. Do not flush unused medications or pour down a sink or drain.
Hot Sale | |
Testosterone enanthate | 315-37-7 |
Testosterone propionate | 57-85-2 |
Testosterone cypionate | 58-20-8 |
Testosterone sustanon | 924-89-0 |
Nandrolone decanoate(deca) | 360-70-3 |
Nandrolone phenylpropionate(duabolin) | 62-90-8 |
Equipoise(boldenone undecylenate) | 13103-34-9 |
Trenbolone acetate(Finaplix H/Revalor-H) | 10161-34-9 |
Trenbolone enanthate | 10161-33-8 |
Drostanolone enanthate(masteron enanthate) | 472-61-1 |
Drostanolone propionate(masteron propioante) | 521-12-0 |
Methenolone enanthate | 303-42-4 |
Methenolone acetate | 434-05-9 |
Dianabol(dbol) | 72-63-9 |
Anavar | 53-39-4 |
Anadrol | 434-07-1 |
Winstrol | 10418-03-8 |
Contact Person: Anne
Tel: +8618702784137